1 Ultrasound Guided Biopsies: What you Need to Know Ulrike M. Hamper, MD; MBA;FACR Russell H. Morgan Department of Radiology and Radiological Sciences Johns Hopkins University School of Medicine Baltimore, Maryland, USA Disclosure Nothing to Disclose No Conflict of Interest ! Image Guided Fine Needle Aspiration Biopsy - FNAB • Replacement of open surgical biopsies in most instances • Advances in cross sectional imaging techniques • Development of different needle types • Refinement in cytopathology techniques • Progress in cancer therapy and more aggressive treatment of metastatic disease and personalized cancer treatment plans (genetic profiling)
30
Embed
Hamper-Ultrasound guided biopsies-what you need to know ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Ultrasound Guided Biopsies:�What you Need to Know
Ulrike M. Hamper, MD; MBA;FACRRussell H. Morgan Department of Radiology and
Radiological SciencesJohns Hopkins University School of Medicine
Baltimore, Maryland, USA
Disclosure
Nothing to Disclose No Conflict of Interest !
Image Guided Fine Needle Aspiration �Biopsy - FNAB
• Replacement of open surgical biopsies in most instances
• Advances in cross sectional imaging techniques• Development of different needle types• Refinement in cytopathology techniques• Progress in cancer therapy and more aggressive
treatment of metastatic disease and personalized cancer treatment plans (genetic profiling)
2
US Guided Interventional Procedures
• Thoracentesis and paracentesis• Aspiration of fluid collections• Organ or mass biopsies• Abscess Drainage• Nephrostomy tube placement• Vascular Access• Tumor Ablation
US FNAB: Objectives
• Indications, Contraindications and Complications
for FNAB (tumor ablation, EV drainages, transperineal prostate biopsies)
• Monitoring by biopsy nurse/anesthesia team
FNAB -Hemostatic Evaluation• Depends on type of procedure• Depends on patients risk factors,
bleeding & medical history and medications (antibiotics, anticoagulants, nonsteroidal anti-inflammatory drugs, vitamins, fish oil etc.)
• Routine laboratory tests except for superficial biopsies (breast, thyroid, lymph nodes) and fluid aspirations
FNAB -Hemostatic Evaluation
• Prothrombin time and Platelet count• Discontinue aspirin for 5-7 days• Discontinue heparin for 4-6 hours• Fresh frozen plasma (FFP) or platelet
transfusion if needed
5
FNAB - Biopsy Technique• Guidance: CT versus US• Size and location of target• Visibility by either modality• Equipment availability• Physician expertise/preference• Careful planning of approach imperative
FNAB - CT Advantages/Limitations
• Guide biopsy in any organ, especially bone or lung
• Accurate image of needle tip• Lack of real-time visualization of
needle during insertion & biopsy• Limited biopsy planes• Longer procedure time, more
expensive, radiation
FNAB - Advantages of US
• Ideal guidance modality• Real time display during biopsy• Unlimited scan planes- “creative
patient positioning”• Speed - faster procedure times• Color Doppler US -vessel visualization
and depiction of viable tissue
6
FNAB - Advantages of US
• Direct pressure over lesion with transducer
• Assess echotexture changes- avoid necrotic or cystic areas in lesion
• Portable for bedside procedures• Lower cost• No radiation
FNAB - US Guidance Limitations
• Poor visualization of certain lesions -surrounded by bone, air, bowel gas
• Patient size may limit visibility• Difficult needle tip visualization• Operator dependence and
availability of suitable equipment
FNAB - US Guidance
• Transabdominal guidance• Transthoracic guidance for pleural
based or mediastinal masses/nodes• Endorectal or endovaginal guidance
for accessible pelvic masses, fluid collections or lymph nodes
7
FNAB - Free Hand Technique
• More difficult to learn or teach
• More flexibility in approach• Transducer may be outside
of sterile field• More difficulty to visualize
needle tip in deep lesions
FNAB - Needle Guides
• Predetermined and controlled path of the needle
• Faster needle placement and tip check
• Easier to teach or learn• 2 people procedure
FNAB - Needle Guides
• Expanded role of US guidance: small deep lesions, retroperitoneal lymph nodes, chest masses
• More difficult if intercostal approach • Preset path and angle difficult for
very superficial lesions
8
FNAB - Needle Tip Visualization
• Needle size or type (echogenic tip)• Angle of needle to US beam• Type of lesion (hypo - vs. is - vs.
hyperechoic target)• Scanning parameters
FNAB - Hints to Improve Needle �Tip Visualization
• Use echogenic needles• Choose the appropriate transducer• Optimize scanning parameters (focal
zone and depth)• Keep needle in center of the beam
and in view at all times
FNAB - Needle Selection
• Small caliber (20-25 g) needles: metastasis vs. primary tumor, thyroid lesions
• Good cytologic, less histologic material
• Better yield with cutting tips• Safe, even to traverse bowel
9
FNAB - Needle Selection
• Large caliber (14 -18g) core biopsy automated devices, min. higher complicatio rate
• Histologic & some cytologic (“touch-prep”) material
• Tumor characterization, benign or fibrotic lesions, parenchymal disease
• Organ rejection (liver, renal, pancreas Tx)
FNAB - Biopsy Technique
• On-site cytopathologist/cytotechnologist for all biopsies
• Start with 22g needle (Franseen or Chiba)• Several passes if necessary for diagnosis
and special stains, immunohistochemistry• Core biopsy (20, 18 or 16g) as deemed
necessary by pathologist or study protocol
FNAB - Biopsy Technique
• Capillary Technique: less bloody, better needle control, less trauma to cells
• Aspiration Technique: Suction with syringe a/o extension tubing for fibrotic tumors and lung lesions (closed system)
10
FNAB - On-Site Cytology
• Advantages: immediate evaluation and optimization of biopsy :- minimum number of passes, assess adequacy of specimens, appropriate staining/processing of specimens
• Disadvantages: Increase in cost and procedure time, not universally available
• Most common biopsy site -focal masses or diffuse liver disease
• Subcostal or intercostal approach• US excellent for high dome lesions• Avoid transpleural biopsy path!• Complications: hemorrhage,
pneumothorax (rare)
11
Metastasis - Lung Carcinoma
Subtle right lobe liver lesionCompound imaging
Hepatocellular Carcinoma
FNAB - Pancreas
• Establish diagnosis of pancreatic ca in unresectable cases (vascular encasement)
• DDx carcinoma from chronic pancreatitis• US guidance 95% accuracy• CT guidance 80 % accuracy, i.v. contrast• Sensitivity 72-90%, Specificity 99-100%• Increasing use of endoscopic US guidance
12
FNAB - Pancreas
• Lower accuracy rates in desmoplastic tumors, atypical cells in pancreatitis
• May need cores in addition to FNA• Transgastric or transcolonic approach• Complication rates: 1.1 - 6.7 %• Deaths: pancreatitis or sepsis (6 cases)• Transplant biopsies with 18 gauge core
Pancreas CarcinomaWith Liver Metastasis
FNAB - Kidney
• Renal mass in non-surgical candidate• Renal mass in patient with other primary tumor• Atypical cystic renal mass• If multiple renal masses: DDx metastases,
lymphoma or multifocal renal cell ca• Growing literature about accuracy of biopsies
and importance for management of small renal tumors
• Core biopsies for renal parenchymal disease or transplant rejection
13
Left Renal Cell Carcinoma
Cystic Renal Cell Carcinoma
FNAB – Adrenal Gland
• To confirm metastatic disease or DDX metastases from adenoma
• Mets: lung, melanoma, renal cell ca• Right adrenal: transhepatic or posterior
approach• Left adrenal: anterior, lateral or posterior
approach- avoid transpancreatic or transpleural path
14
Right Adrenal Mass- Transhepatic Approach
Adrenal Metastasis from Prostate Cancer
Adrenal Metastasis from Prostate Cancer
anterior approach posterior decubitus approach
15
FNAB - Retroperitoneal Masses
• Sarcomas, lymphoma and metastases• Pelvic and retroperitoneal adenopathy:
easily biopsied under US with guide• Transducer pressure compresses bowel
and decreases depth to target• Visceral penetration usually not a
problem• CDUS: avoid injury to vessels
Left para-aortic adenopathy
Hodgkin Lymphoma
Left Para-aortic Mass
Left paraoartic mass on CT Large B-cell Lymphoma
16
Para-aortic Adenopathy- Metastatic Adenoca
Para-aortic Adenopathy- Metastatic Adenoca
FNAB - Lymphoma
• Accuracy lymphoma < metastases• FNAB plus core biopsies (subtype,
histologic grade (esp. Hodgkin disease)• DNA flow cytometry, molecular and
• CT review prior to procedure helpful• Appropriate antibiotic coverage.
27
Left Presacral Mass
Anterior approach
Left Presacral Mass
Schwannoma
endorectal approach
Left Pelvic Node Biopsy�
anterior approach
B
28
Left Pelvic Node Biopsy�
Metastatic Prostate Ca
posterior approach
FNAB - Pitfalls
• Non diagnostic specimen: scant cellularity, necrotic lesion
• False negative result: sampling error: lesion not sampled or sample not representative of the entire lesion
• False positive result: rare, however may occur
FNAB - Negative Pathology
• Only acceptable if the diagnosis of non-malignancy can be explained by lesion or imaging characteristics: e.g. scar tissue, infarction or inflammation
• Repeat biopsy if non-diagnostic: e.g. insufficient material or material not representative of lesion and imaging abnormality
29
FNAB – Keys to Success
• Careful review of patient’s history other and imaging studies
• Good technique and equipment to obtain sufficient sample
• Interpret pathology in context of clinical and imaging findings